Stay updated with breaking news from Nyse Dyn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report) shares rose 5.9% during mid-day trading on Tuesday . The company traded as high as $19.57 and last traded at $19.09. Approximately 990,808 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 8,243,103 shares. The stock had previously closed at […]
StockNews.com upgraded shares of Dyne Therapeutics (NYSE:DYN – Free Report) to a sell rating in a report published on Friday morning. Several other research analysts have also commented on DYN. Chardan Capital reiterated a buy rating and set a $20.00 price objective on shares of Dyne Therapeutics in a research note on Friday, August 4th. […]
Dyne Therapeutics (NYSE:DYN – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.99) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.16), MarketWatch Earnings reports. Dyne Therapeutics Price Performance Shares of NYSE DYN opened at $7.05 on Wednesday. The stock’s 50-day simple moving average is […]
Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $8.96, but opened at $9.20. Dyne Therapeutics shares last traded at $8.88, with a volume of 4,391 shares traded. Wall Street Analyst Weigh In Several analysts recently weighed in on DYN […]
Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report) insider Richard William Scalzo sold 1,290 shares of the business’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $9.41, for a total value of $12,138.90. Following the completion of the sale, the insider now owns 40,795 shares in […]